Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 2Enrolling by invitation 1

Sponsor Class

OTHER 1NIH 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 1Colonic Neoplasms 1Bone Diseases, Metabolic 1

Interventions

Cyclophosphamide 1499Cisplatin 1435Paclitaxel 1340Radiotherapy 1310Carboplatin 1267Gemcitabine 1226Docetaxel 1133Bevacizumab 1070Fluorouracil 906Doxorubicin 805Dexamethasone 755Rituximab 744Capecitabine 735Oxaliplatin 709pembrolizumab 700Etoposide 679Irinotecan 639Filgrastim 624Cytarabine 587Nivolumab 586Leucovorin 583Vincristine 517Cetuximab 479Prednisone 478Bortezomib 474Trastuzumab 468Erlotinib Hydrochloride 467Surveys and Questionnaires 460Methotrexate 444Lenalidomide 436

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Radiography, Panoramic × Clear all
NCT00002968 2026-06-01

Edrecolomab in Treating Patients With Stage II Colon Cancer

National Cancer Institute (NCI)

Phase 3 Completed
2,100 enrolled
Gastrointestinal

Colonic Neoplasms

NCT04213482 2019-12-30

Evaluating Radiomorphometric Indices and Fractal Dimension of the Pediatric Oncology Patients on Panoramic Images

Nuh Naci Yazgan University

Completed
100 enrolled

Bone Diseases, Metabolic, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡